0000873303-12-000005.txt : 20120425
0000873303-12-000005.hdr.sgml : 20120425
20120425171826
ACCESSION NUMBER: 0000873303-12-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120424
FILED AS OF DATE: 20120425
DATE AS OF CHANGE: 20120425
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Christopher Nishan Garabedian
CENTRAL INDEX KEY: 0001492604
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 12780478
MAIL ADDRESS:
STREET 1: 333 RIVER STREET
STREET 2: #303
CITY: HOBOKEN
STATE: NJ
ZIP: 07030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVI BIOPHARMA INC
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: OR
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3450 MONTE VILLA PARKWAY
STREET 2: SUITE 101
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 425-354-5038
MAIL ADDRESS:
STREET 1: 3450 MONTE VILLA PARKWAY
STREET 2: SUITE 101
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0305
4
2012-04-24
0
0000873303
AVI BIOPHARMA INC
AVII
0001492604
Christopher Nishan Garabedian
3450 MONTE VILLA PARKWAY, SUITE 101
BOTHELL
WA
98021
1
1
0
0
President and CEO
Common Stock
2012-04-24
4
A
0
81666
0
A
511666
D
Stock Option (right to buy)
0.9
2012-04-24
4
A
0
245000
0
A
2022-04-24
Common Stock
245000
245000
D
Of the 511,666 shares beneficially owned following the reported transaction, 81,666 relate to restricted stock units granted on the Transaction Date and 430,000 reflect shares of common stock directly beneficially owned by reporting person.
This option is exercisable at the rate of 25% of the shares on April 24, 2013 and 1/48th of the total granted shares on each monthly anniversary thereafter, such that the option will be fully exercisable on April 24, 2016.
By: Bryan King For: Christopher Nishsan Garabedian
2012-04-25